Truist maintains Buy rating, $61 target on ONON shares following dip
Truist Securities maintained its Buy rating and $61.00 price target for On Holding AG (NYSE:ONON) stock. The firm's stance comes after a noticeable decline in the company's shares, which have fallen ...
Truist says AnaptysBio handing of placebo ‘raise doubt’ about Phase 2 RA data
Truist notes that AnaptysBio (ANAB) reported the “much anticipated” results of its Phase 2b trial of rosnilimab for moderate-to-severe ...
Truist Financial Reaffirms Their Buy Rating on Crispr Therapeutics AG (CRSP)
Truist Financial analyst Joon Lee maintained a Buy rating on Crispr Therapeutics AG (CRSP – Research Report) today. The company’s shares closed ...
Truist Checking Account Review: Fees, Perks & Features
Discover Truist’s checking account features, fees, and benefits in our comprehensive review. Learn how to maximize perks and ...
Truist lifts Boston Scientific stock target to $120, maintains Buy
Truist Securities expressed a positive outlook on Boston Scientific (NYSE:BSX) shares, raising the price target to $120 from $110, while reaffirming a Buy rating. The stock, currently trading near its ...